112 related articles for article (PubMed ID: 37097647)
1. C4orf47 Contributes to the Induction of Stem-like Properties in Gallbladder Cancer Under Hypoxia.
Na L; Masuda S; Nagao S; Morisaki S; Iwamoto N; Sakanashi K; Onishi H
Anticancer Res; 2023 May; 43(5):1925-1932. PubMed ID: 37097647
[TBL] [Abstract][Full Text] [Related]
2. C4orf47 contributes to the dormancy of pancreatic cancer under hypoxic conditions.
Nagao S; Onishi H; Kawamoto M; Masuda S; Na L; Morisaki S; Iwamoto N; Yamada Y; Koga S; Ichimiya S; Nakayama K; Imaizumi A; Nakashima K; Oda Y; Nakamura M
J Cancer; 2023; 14(2):306-317. PubMed ID: 36741255
[TBL] [Abstract][Full Text] [Related]
3. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog signaling pathway is a potential therapeutic target for gallbladder cancer.
Matsushita S; Onishi H; Nakano K; Nagamatsu I; Imaizumi A; Hattori M; Oda Y; Tanaka M; Katano M
Cancer Sci; 2014 Mar; 105(3):272-80. PubMed ID: 24438533
[TBL] [Abstract][Full Text] [Related]
5. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
6. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.
Xu G; Wei X; Tu Q; Zhou C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
8. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
9. FOXA2 suppresses gallbladder carcinoma cell migration, invasion, and epithelial-mesenchymal transition by targeting SERPINB5.
Hong L; Chen M; Huang M; Chen W; Abudukeremu X; She F; Chen Y
Environ Toxicol; 2024 Feb; 39(2):708-722. PubMed ID: 37665156
[TBL] [Abstract][Full Text] [Related]
10. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.
Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
Mol Biol Rep; 2014 Jul; 41(7):4507-12. PubMed ID: 24623408
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
13. GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
Ichimiya S; Onishi H; Nagao S; Koga S; Sakihama K; Nakayama K; Fujimura A; Oyama Y; Imaizumi A; Oda Y; Nakamura M
Oncol Rep; 2021 Mar; 45(3):997-1010. PubMed ID: 33650666
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer.
Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z
Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA.
Yan J; Dai P; Qin X; He Y; Zhang Y
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913073
[TBL] [Abstract][Full Text] [Related]
16. MAML3 Contributes to Induction of Malignant Phenotype of Gallbladder Cancer Through Morphogenesis Signalling Under Hypoxia.
Na L; Onishi H; Morisaki S; Ichimiya S; Yamada Y; Masuda S; Nagao S; Koga S; Nakayama K; Imaizumi A; Oda Y; Nakamura M
Anticancer Res; 2023 Jul; 43(7):2909-2922. PubMed ID: 37351966
[TBL] [Abstract][Full Text] [Related]
17. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
19. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma.
Wang N; Xiang X; Chen K; Liu P; Zhu A
Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108
[TBL] [Abstract][Full Text] [Related]
20. IL-37 suppresses migration and invasion of gallbladder cancer cells through inhibition of HIF-1α induced epithelial-mesenchymal transition.
Wu TJ; Xu B; Zhao GH; Luo J; Luo C
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8179-8185. PubMed ID: 30556856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]